Prevalence of Identified Gout
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
The prevalence of identified gout in those enrolled with primary health organisations (PHOs), by DHB (percent).
Numerator
Those aged 20 years and over identified with gout using the HealthTracker method from a public hospital admission from 1 January 1988 to 31 December 2019 or who have been dispensed gout-specific urate lowering therapy (allopurinol, febuxostat, benzbromarone) or colchicine from a community pharmacy between 2001 and 2019.
Denominator
Statistics New Zealand population aged 20 and over, using 2019 projections.
Exclusions
Patients with a diagnosis of leukaemia or lymphoma.
Use of Risk Adjustment
Risk Adjustments
Stratifications
By year (2012-2019), age group (20-44, 45-64, 65+) and ethnicity (Māori, Pacific peoples, non-Māori, non-Pacific).
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Ministry of Health: National Minimum Dataset, Pharmaceutical Collection, PHO enrolments, Mortality Collection, New Zealand Cancer Registry (numerator). Stats NZ: population projections (denominator).
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Atlas of Healthcare Variation website